Starting naltrexone or acamprosate while working full time

TLDR

• Both first-line alcohol medications, naltrexone and acamprosate, are designed for outpatient life. No leave of absence, no program enrollment, no disclosure to your employer is required to take a daily prescription.¹²
• The side-effect window is front-loaded and manageable. Naltrexone's most common effect is nausea in the first one to two weeks; acamprosate's is gastrointestinal upset. Most people work through both. Plan the first dose for a Friday if you want a buffer.²⁵
• Timing is flexible by design: naltrexone is once daily (or targeted before drinking), acamprosate is three times daily, and neither is sedating or impairing at work.
• Colleagues notice far less than you expect. There is no visible sign of either medication, and "I'm not drinking tonight" needs no explanation beyond the ones nondrinkers use every day.
• If your drinking level risks withdrawal when you cut back, that is a separate medical question to settle with your prescriber first. Review your FMLA options before you need them, not after.

The practical question for an employed person with a drinking problem is rarely "does treatment exist." It is whether treatment fits between a Monday standup and a Thursday client dinner. For medication for alcohol use disorder, usually shortened to MAUD, the honest answer is yes, and this article walks through the mechanics: what the first weeks feel like, how to time doses, and how to handle the work situations that worry people most.

What you are starting, briefly

Two medications carry first-line evidence for alcohol use disorder:¹²

• Naltrexone, 50 mg oral, taken either daily or targeted about an hour before drinking. It blocks opioid receptors, which blunts the reward loop alcohol relies on. Meta-analyses put its number needed to treat in the range of 12 to 20 to prevent return-to-drinking outcomes, comparable to widely used medications across general medicine.¹² The targeted-dosing protocol is covered in detail in our Sinclair Method guide.
• Acamprosate, typically two 333 mg tablets three times daily, supports abstinence after stopping by stabilizing the glutamate system that heavy drinking dysregulates. Its number needed to treat to prevent return to any drinking is approximately 11.¹²

The selection logic is reasonably clean. Clinicians often note that naltrexone suits a goal of reduced or controlled drinking and works whether or not you have stopped, while acamprosate suits a goal of maintaining abstinence already begun, and is the default with significant liver concerns since it is not hepatically metabolized.² Both are generic, inexpensive, and prescribable by any primary care clinician or telehealth platform; the full comparison lives in our MAUD overview.

One safety gate before anything else. Naltrexone is incompatible with opioids in any form and will precipitate withdrawal in anyone physically dependent on them. And if your body is dependent enough on alcohol that cutting back sharply brings shakes or sweats, discuss clinician-supervised withdrawal management before changing your intake. Neither issue rules out MAUD; both change the sequence.²

Week one: what side effects actually look like

The evidence on tolerability is reassuring but worth knowing in advance. For naltrexone, the most common adverse effects are nausea, headache, dizziness, and fatigue, concentrated in the first one to two weeks and typically resolving as the body adjusts. Taking the dose with food reduces nausea meaningfully, and some prescribers start at 25 mg for several days before stepping up to 50 mg. For acamprosate, the most common effect is diarrhea or softer stools, which usually settles within a couple of weeks. Neither medication is sedating, neither impairs cognition or driving, and neither shows up on workplace drug panels, which test for substances of misuse, not treatment medications.²⁵

Now translate that into calendar terms. Start on a Thursday night or Friday so the roughest adjustment days land on a weekend. Keep the first week free of high-stakes presentations if you can; mild nausea while presenting quarterly numbers is avoidable with a one-week shift. Put the dose somewhere automatic, with dinner for evening dosing or in the coffee routine for morning, because the medication only works at the rate you actually take it. If week one is rough, the move is a message to your prescriber about dose ramping, and quitting on day four is the most common preventable failure.

Dosing logistics in a work week

• Naltrexone daily dosing is one tablet, any consistent time. Evening dosing hides any transient fatigue inside sleep. Nothing about it is visible at work.
• Naltrexone targeted dosing requires one hour of lead time before drinking. For planned events, a client dinner or a wedding, that means a dose at your desk or in the car beforehand. The pill is small and the act is indistinguishable from taking ibuprofen.
• Acamprosate's three-times-daily schedule is the main adherence challenge for working people. The realistic pattern: morning dose with breakfast, midday dose with lunch (a pill organizer in a bag or desk drawer reads as vitamins to anyone who notices, and almost no one notices), evening dose with dinner. Phone reminders labeled something neutral do the remembering.
• Refills and privacy. Both generics cost little even without insurance through pharmacy discount programs, which also keeps the claim off your employer-sponsored plan's record if that matters to you. Telehealth MAUD platforms ship to your door. No system here requires an employer's awareness, though insurance claims and pharmacy records are medical data like any other: more private than telling your manager, never perfectly invisible.

The happy hour problem

The work event built around alcohol is the most cited fear, and it is more manageable than it looks from the inside.

If you are on targeted naltrexone and your plan includes drinking at the event, the protocol is unchanged: dose an hour ahead, drink as planned, notice that it is less interesting than usual. That is the method working.

If your goal is not drinking at the event, three observations from people who do this every week:

1. Nobody is tracking your glass. The level of scrutiny we imagine from colleagues exceeds the reality by an order of magnitude. A soda water with lime is socially invisible.
2. A script beats improvisation. "I'm not drinking tonight, early start tomorrow" closes the topic in nine words. So does "I'm on a medication that doesn't mix with alcohol," which is true, requires no elaboration, and applies to half the prescriptions in America. Have one sentence ready and the question loses its power.
3. Plan the exit before you arrive. Decide the departure time in advance, and book something true for afterward. The last hour of a happy hour serves no professional purpose.

Our guide to managing high-risk professional events goes deeper on the social mechanics.

The first 90 days, mapped

Weeks 1 to 2: adjustment. Side-effect window, routine building. Track drinks per week and craving intensity in any notes app; a baseline measured now is what makes month three legible. Expect modest change at most. The medication is necessary but rarely sufficient alone, and pairing it with any structured support, a therapist using CBT-based approaches, a SMART Recovery meeting at lunch online, measurably improves outcomes.¹³

Weeks 3 to 6: pattern emergence. On naltrexone, many people report the second drink losing its pull, or finishing the work week without the Friday bottle feeling inevitable. On acamprosate with an abstinence goal, this is where the background noise of wanting a drink starts dropping. Sleep often improves in this window, which compounds at work.

Weeks 6 to 12: evaluation with data. Bring the log to your follow-up. A meaningful drop in heavy-drinking days is a continue signal. A flat line despite honest adherence means adjusting: switching agents, combining medication with more behavioral support, or revisiting the diagnosis with your prescriber. Both medications are tools, and tools get swapped when they underperform.²

One more piece of proactive planning, even though most people starting MAUD never need it: review your FMLA options now. If you qualify, the Family and Medical Leave Act protects intermittent leave for treatment appointments, not just continuous absences, and knowing the mechanics before any crisis means you act from a plan rather than a panic. The same logic applies to understanding ADA protections for people in recovery. Our professional protections guide covers both, including the timing rules that make proactive requests materially safer than reactive ones.⁴

The bottom line

Starting naltrexone or acamprosate while employed full time is not a workaround; outpatient daily life is the setting these medications were validated in. The realistic plan: clear the safety gates with a prescriber, start on a Friday, take the dose with food, script one sentence for social events, track your numbers, and judge the experiment at twelve weeks with data. The career risk of a managed, medicated, measurable change to your drinking is close to zero. The status quo is the riskier asset.

What to read next

• Medications for Alcohol Use Disorder: The Overview
• FMLA, ADA, and Licensing Boards: A Professional's Guide
• The Sinclair Method: What the Evidence Says

Sources